Aclaris Therapeutics
Presence
Aclaris Therapeutics is one of the...
Aclaris Therapeutics is a company listed under the stock ticker ACRS (US).
Executives
View the org chart displaying its 28 main executives
Most searched biographies at Aclaris Therapeutics
- Neal Walker, Interim Chief Executive Officer and Chairman of the B...
- Andrew Schiff, Director
- Andrew Powell, Director
Popular executive movements at Aclaris Therapeutics
- Neal Walker, who was Chairman of the Board, is promoted to Interim Chief Executive Officer and Chairman of the Board (posted on January 17 2024).
- Douglas Manion, Director, President and Chief Executive Officer, has left the company (posted on January 17 2024).
Create your alert
to follow the executive moves at Aclaris Therapeutics.
Pharmaceuticals
Aclaris Therapeutics has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Aclaris Therapeutics
- Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Expands Leadership Team | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Expands Leadership Team | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Provides R&D Update | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Expands Leadership Team | Aclaris Therapeutics, Inc.
- Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update | Aclaris Therapeutics, Inc.
- View more press releases Close
Social media about Aclaris Therapeutics
- Aclaris Therapeutics on Wikipedia, Google News & Yahoo Finance
- Aclaris Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Neal Walker 
Call Aclaris Therapeutics at +1 484...
